← back to search

Esther E. Freeman

Harvard University · US
Area of research
Oncology · Dermatology
Research interest
Research interests include Dermatological and COVID-19 studies, Viral-associated cancers and disorders, HIV/AIDS Research and Interventions, and Cutaneous Melanoma Detection and Management.
h-index
34
citations
6,901
works
189
NIH funding
primary concept
Medicine
email

Recent publications

The need for African dermatology guidelines-Steps towards equitable care.
2026cited by 0position: contributordoi
Characterizing global dermatologic engagement and needs: A cross-sectional study from 83 countries.
2026cited by 0position: contributordoi
AI and Digital Tools in Dermatology: Addressing Access and Misinformation.
2026cited by 0position: contributordoi
Polatuzumab vedotin extravasation injury: a case report.
2025cited by 1position: contributordoi
Peer Navigation for HIV-Associated Kaposi Sarcoma in Kenya: The Power of the Survivor's Voice.
2025cited by 1position: contributordoi
Tools to strengthen skin neglected tropical disease training in resource-limited settings.
2025cited by 0position: contributordoi
Advancing Equity and Inclusion in Global Dermatology Research: Strategies and Methodological Considerations.
2025cited by 0position: contributordoi
Livedo racemosa as the presenting symptom of microscopic polyangiitis.
2025cited by 0position: contributordoi
Measles resurgence: What every dermatologist should know.
2025cited by 0position: contributordoi
Emerging challenges in global health dermatology: measuring impact and sustainability.
2025cited by 0position: contributordoi
Rethinking neglected tropical diseases: A shift towards more inclusive and equitable terminology.
2025cited by 0position: contributordoi
Guidelines of care for the management of acne vulgaris
Journal of the American Academy of Dermatology 2024cited by 382position: middledoi
Guidelines of care for the management of acne vulgaris.
2024cited by 223position: contributordoi
Impact of a multicomponent navigation strategy on stigma among people living with HIV and Kaposi's sarcoma in Kenya: a qualitative analysis.
2024cited by 8position: contributordoi
The impact of COVID-19 vaccine reactions on secondary vaccine hesitancy.
2024cited by 5position: contributordoi
Dermatology's role in the fight against human trafficking: A report from the AAD Ad Hoc Task Force and call to action.
2024cited by 4position: contributordoi
HIV and mpox: Evaluation of clinical course and outcomes from an international dermatologic registry.
2024cited by 1position: contributordoi
Expanding global health dermatology leadership: launching the GLODERM international mentorship programme.
2024cited by 1position: contributordoi
Usability of a smartphone-compatible, confocal micro-endoscope for cervical cancer screening in resource-limited settings.
2024cited by 0position: contributordoi
Inclusive and equitable language for skin colour in the British Journal of Dermatology: acknowledging our past and laying the foundations to move forward.
2024cited by 0position: contributordoi
A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring
Journal of the American Academy of Dermatology 2023cited by 79position: lastdoi
A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring.
2023cited by 44position: contributordoi
Urticaria after COVID-19 vaccination and vaccine hesitancy.
2023cited by 12position: contributordoi
Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry.
2023cited by 12position: contributordoi
Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
2023cited by 11position: contributordoi
Monkeypox emerges on a global scale: A historical review and dermatologic primer.
2023cited by 8position: contributordoi
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry.
2023cited by 8position: contributordoi
Proposing a standardized assessment of COVID-19 vaccine-associated cutaneous reactions.
2023cited by 5position: contributordoi
Global health dermatology: An emerging field addressing the access to care crisis.
2023cited by 3position: contributordoi
The BJD's approach to global health and equity in publishing: adding author reflexivity statements.
2023cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Kimberly G. Blumenthal · Mayo Clinic in Florida18 papers (2021–2024)Devon E. McMahon · Brigham and Women's Hospital15 papers (2020–2023)Lars E. French · ERN Skin12 papers (2020–2023)George J. Hruza · UConn Health12 papers (2020–2023) · 11 papers (2021–2026)Lindy P. Fox · Stanford University11 papers (2020–2022)Misha Rosenbach · Carol Davila University of Medicine and Pharmacy10 papers (2020–2023)Henry W. Lim · Henry Ford Health System8 papers (2020–2023)Jules B. Lipoff · Temple College7 papers (2020–2021)Seemal R. Desai · Innovate UK7 papers (2020–2024)B.H. Thiers · Medical University of South Carolina6 papers (2020–2021) · 5 papers (2021–2022)Phyllis I. Spuls · Amsterdam UMC Location University of Amsterdam4 papers (2020–2021)Alan D. Irvine · Evelina London Children's Healthcare4 papers (2020–2023) · 4 papers (2021–2024)Aggrey Semeere · Infectious Diseases Institute4 papers (2017–2022)Jeffrey N. Martin · Global Solutions for Infectious Diseases4 papers (2017–2025) · 4 papers (2021–2021)Rodney Sinclair · Melbourne Health4 papers (2020–2021)Carrie Kovarik · California University of Pennsylvania3 papers (2020–2021)